“…AD is a neurodegenerative disease characterized by cholinergic deficits, neuronal loss, glial dysfunction ( Echeverria et al, 2009 ), intracellular and extracellular accumulation of aggregated forms of Aβ, and the appearance of intraneuronal neurofibrillary tangles of hyperphosphorylated Tau in the brain ( McGeer, 1986 ; Mann, 1989 ; Masdeu et al, 2005 ). The main risk factors involve traumatic brain injury ( Gardner and Yaffe, 2015 ; Daulatzai, 2017 ), posttraumatic stress disorder (PTSD) ( Tsolaki et al, 2009 ; Meziab et al, 2014 ; Ritchie et al, 2019 ), diabetes ( Chen and Zhong, 2013 ; Boccardi et al, 2019 ; Jash et al, 2020 ), and age ( Simpson et al, 2010 ; Bartzokis, 2011 ; Bove et al, 2014 ). These abnormalities occur with neuroinflammation and oxidative stress that orchestrate a cascade of events leading to cognitive decline, gliosis, and synaptic loss.…”